NextCure, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
NXTC Company Description
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.
NXTC Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NXTC Smart Score
Score Breakdown
NXTC Company Description
Show More
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of NXTC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NXTC's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on NXTC's company Twitter account
WallStreetBets
Number of mentions of NXTC in WallStreetBets Daily Discussion
NXTC News
Recent insights relating to NXTC
CNBC Recommendations
Recent picks made for NXTC stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NXTC
Corporate Flights
Flights by private jets registered to NXTC
Our Analysis